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Abstract
Background: Hereditary spastic paraplegia is a large group of degenerative, neurological disorders characterized by
progressive lower limb spasticity and weakness. The disease was investigated precisely but still clinicians often make
incorrect or late diagnosis. Our aim was to investigate the genetic background and clinical phenotype of spastic
paraplegia in large Polish family.
Case presentation: A 37 years old woman presented with 4-year history of walking difficulties. On neurological
examination, she had signs of upper motor lesion in lower extremities. She denied sphincter dysfunction and her
cognition was normal. Her family history was positive for individuals with gait problems. The initial diagnosis was
familial spastic paraplegia. Genetic testing identified a novel mutation in SPAST gene. All available family members
were examined and had genetic testing. The same mutation in SPAST gene was identified in other affected family
members. All patients caring the mutation presented with different phenotypes.
Conclusion: This study presents a family with spastic paraplegia due to a novel mutation c.1390G›T(p.Glu464Term)
in SPAST gene. Affected individuals showed a range of phenotypes that varied in their severity. This case report
demonstrates, the signs of hereditary spastic paraplegia can be often misdiagnosed with other diseases. Therefore
genetic testing should always be considered in patients with lower limb spasticity and positive family history in
order to help to establish the correct diagnosis.
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Background
Hereditary spastic paraplegias (HSPs) are a rare and het-
erogeneous group of neurodegenerative disorders char-
acterized by slowly progressive spasticity and weakness
of lower extremities. Its prevalence varies from 1.2 to
9.6/100000 [1].
HSPs are classified by the phenotype, the trait of
inheritance and the mutated gene. Based on the pheno-
type, HSPs are classified as pure when spastic paraplegia
is the only symptom or complex when it is associated
with other clinical features like involvement of upper
extremities, cognitive impairment and behavioral
changes.
The most commonly involved are SPAST and ATL1
genes. Mutations in the SPAST on chromosome 2p22.3
account for 15–40% of all autosomal dominant HSPs
cases [2]. It encodes the protein spastin, a member of
the ATPase associated with diverse cellular activity
family with a role in microtubule dynamics.
Clinically, HSPs due to mutations in SPAST, present
as a pure form in most cases but phenotypic variations
are also reported [3].
Strategy for exploration of gene of interest is guided
by clinical presentation, model of inheritance, and age of
onset. In our case, the pure clinical form, autosomal
dominant pattern of inheritance, and age of onset above
20 years led us to begin with exploring SPAST gene.
Genetic studies identified a new mutation in AAA-
domain of SPAST gene. To confirm the pathogenicity of
this mutation we used computational predictive pro-
grams and additionally we assessed co-segregation in
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affected family members. Those who had signs of upper
motor lesion and had been previously diagnosed with
other diseases, carried the same mutation.
Case presentation
A 37 years old woman (E) presented with walking difficul-
ties. The first symptoms began 4 years prior to presenta-
tion when she noticed walking more slowly. She had no
other complaints, denied previous and current use of
drugs. Some other members of her family also experi-
enced gait problems. (Fig. 1 presents the pedigree of the
family. Table 1. presents characteristics of family
members.)
On neurological examination, she had spastic gait,
symmetrical proximal weakness of the lower extremities
(quadriceps and gluteal muscle), mild spasticity in ham-
strings, quadriceps, adductors, gastrocnemius, and so-
leus. Increased deep tendon reflexes and Babinski sign
were present bilaterally. She denied sphincter dysfunc-
tion. Her cognition was normal.
Laboratory tests did not reveal any abnormalities in
blood count, electrolytes value, coagulation test, renal,
hepatic or thyroid functions. C-reactive protein was ‹ 1
mg/L. Vitamin B12 level was normal. The nerve conduc-
tion study and evoked visual potentials were normal.
Spinal and brain MR showed normal appearance of cor-
pus callosum and did not find any cause of pyramidal syn-
drome. She was diagnosed with progressive pyramidal
syndrome exclusively involving lower extremities. Her ini-
tial diagnosis was HSP.
After a written consent was obtained from the patient,
the blood was taken for genetic testing. Molecular DNA
analysis of the SPAST gene was performed. The Sanger
sequencing method revealed mutation in one allele of
SPAST gene: c.1390G›T(p.Glu464Term). This variant
was not registered in the following genetic public
database: HGMD, LOVD, NCBI ClinVar, dbSNP and
ExAC. To determine pathogenicity in silico of this vari-




blood samples for DNA testing were collected from 7
other available family members. The work was con-
ducted in accordance with the Declaration of Helsinki.
The same mutation was identified in 3 other pro-
bands (A,F,G). The pathogenicity of the novel muta-
tion found in this study was categorized according to
the guidelines of the American College of Medical
Genetics and Genomics [4]. Under this criteria this
mutation was classified as pathogenic (Criteria: PVS1,
PM1, PM2, PM4).
Patient (A), 56 years old woman, did not complain of
any neurological symptoms or gait difficulties but pre-
sented with brisk reflexes and bilateral Babinski sign on
neurological examination.
Patient F, 57 years old woman, suffered from polio
disease when he was 8, with right hemiparesis and full
recovery after a few months. At the age of 37, he experi-
enced increasing walking difficulties. He was diagnosed
with post-polio syndrome. At the age of 39 he was un-
able to work as a carpenter.
On neurological examination, he had spastic gait with
heel strike progressively shifted forward, and asymmetrical
proximal weakness of the lower extremities, more ad-
vanced on the right one. Severe spasticity in quadriceps,
hamstrings, thigh adductor muscles, gastrocnemius and
soleus was also found. Increased deep tendon reflexes in
lower limbs and Babinski sign were present bilaterally. He
denied sphincter dysfunction. His cognition was normal.
Another family member (G), 51 years old man, started
to experience problems in her late thirties. She was
Fig. 1 Pedigree of a family with spastic paraplegia. Black circles (females) and squares (males) represent affected people with spastic paraplegia.
Cross-hatched symbols represents affected individuals already deceased (1,2,3,4,5,6,7,8). Unaffected individuals are not shaded. Individuals A,B,C, D,
E, F, G, H had neurological and genetic evaluations
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admitted to the hospital in 2007. Cerebrospinal fluid
analysis and laboratory tests did not reveal any abnor-
malities. The nerve conduction study was normal. The
cervical and thoracic MR shoved disc herniation with
suspicion of spinal cord suppression on multiple levels.
Patient was discharged from the hospital with diagnosis
of lower limb spasticity due to disc herniation: Th6/Th7
and Th8/TH9 and qualified for neurosurgery. Before
agreeing to the surgery she sought neurosurgery consult-
ation in another clinic. She had another thoracic spine
MR, confirming multilevel disc herniation, but the signal
of the spine was not changed, therefore she was disquali-
fied from operation. Since that time, she observed slow
progression of disability despite constant rehabilitation.
On neurological examination, she had spastic gait,
symmetrical weakness of the lower limbs, mild spasti-
city in hamstrings, quadriceps, adductors, gastrocne-
mius, and soleus. Increased deep tendon reflexes in
lower limbs and Babinski sign were present bilaterally.
She did not report any sphincter dysfunction. Her
cognition was normal.
The other genotyped family members (B,C,D,H) had
no clinical and neurological symptoms and signs, and
did not carry the mutation.
Our observational study indicates that novel variant
c.1390G›T(p.Glu464Term) in SPAST gene is associated
with HSP.
Patient has provided informed consent for publication
of the case.
Discussion and conclusions
The novel mutation was identified in the AAA-domain
of SPAST, region where most identified so far variants
were located and still new studies confirm this observa-
tion [5].
As described before, the clinical expression of muta-
tions in SPAST gene within a family may vary from
asymptomatic patients, mildly affected individuals to
severely affected patients [3]. Our study confirms this
observation; the phenotype of affected family mem-
bers varied from absence of clinical symptoms and
complains to severe disability. The onset of symptoms
was above 30 years of age in all cases, there was no
association with sex and affected parent age at onset,
what is consistent with previous studies [6].
To summarize, our study presents a family with a
novel mutation in SPAST gene. The affected family
members presented with different clinical phenotypes.
The medical history of affected subjects shoves that
clinical symptoms characteristic for HSP can be mis-
diagnosed with other diseases. Therefor in patients
with spastic paraparesis and positive family history for
gait problems, the HSP should be suspected at the
top of differential diagnosis list and genetic testing
should be considered.
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